clindamycin and benzoyl peroxide NDC 16714-984

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-984Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0984Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-984-25	16714098425	1 JAR in 1 CARTON (16714-984-25) / 25 g in 1 JARMarketed from Jul 1, 2019
16714-984-50	16714098450	1 JAR in 1 CARTON (16714-984-50) / 50 g in 1 JARMarketed from Jul 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): clindamycin and benzoyl peroxide
Generic name (nonproprietary): clindamycin and benzoyl peroxide
Active ingredients: Clindamycin phosphate — 10 mg/gBenzoyl peroxide — 50 mg/g
Dosage form: Gel
Route: Topical
Labeler: NorthStar RxLLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209252
Marketing start: Jul 1, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 16714-984_35611701-add1-42d0-9fc2-58368001602aSPL ID 35611701-add1-42d0-9fc2-58368001602aSPL set ID e19de12c-f29b-42ab-9e81-1af8e4a66643RxCUI 358917UNII EH6D7113I8, W9WZN9A0GMUPC 0316714984254, 0316714982021
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714098425 followed by a unit qualifier and the quantity

Package 16714-0984-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 4, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin and Benzoyl Peroxide Gel is indicated for the topical treatment of acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209252

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209252
Product	Strength	Form · route	Labeler	Product NDC
clindamycin and benzoyl peroxide	Clindamycin phosphate 10 mg/g; Benzoyl peroxide 50 mg/g	GelTopical	Glenmark Pharmaceuticals Inc., USA	68462-486
clindamycin and benzoyl peroxide	Clindamycin phosphate 10 mg/g; Benzoyl peroxide 50 mg/g	GelTopical	Glenmark Pharmaceuticals Inc., USA	68462-859